戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 while maintaining PM perfusion, confirmed by contrast echocardiography.
2 d ethanol injection technique and the use of contrast echocardiography.
3  the presence and size of a PFO using saline contrast echocardiography.
4 as determined by intravenous (IV) myocardial contrast echocardiography.
5 ho enhancement by QW7437 microbubbles during contrast echocardiography.
6 w reserve are possible using second harmonic contrast echocardiography.
7  flow (MBF) were completed with standard and contrast echocardiography.
8 rial pacing with high-resolution Doppler and contrast echocardiography.
9 lative to the cell counts at sham myocardial contrast echocardiography.
10 PAVA was assessed using transthoracic saline contrast echocardiography.
11 ocardial perfusion produced by IV myocardial contrast echocardiography.
12                                   Myocardial contrast echocardiography accurately differentiates 'stu
13 size and perfusion defect size on myocardial contrast echocardiography after reperfusion (r = .82), w
14 o a stenosis can be measured with myocardial contrast echocardiography, allowing coronary stenosis de
15                                   Myocardial contrast echocardiography allows real-time echocardiogra
16 arct size and perfusion defect on myocardial contrast echocardiography also remained good in the pres
17 m and detect coronary stenosis by myocardial contrast echocardiography and (2) compared the response
18 graphy and fluoroscopy as well as epicardial contrast echocardiography and angiography at the time of
19 ients with the use of dipyridamole real-time contrast echocardiography and followed them for a median
20 -um microspheres and compared the results to contrast echocardiography and MIGET-determined gas excha
21                  We sought to compare bubble contrast echocardiography and pulmonary angiography in d
22 e heart block, but the risk was reduced with contrast echocardiography and slow ethanol injection.
23 specimens obtained 24 hours after myocardial contrast echocardiography and then either fresh frozen o
24  anatomical shunt with 25-um microspheres to contrast echocardiography, and gas exchange shunt measur
25 inase (CK), smaller septal area opacified by contrast echocardiography, and higher residual gradient
26 ological advances have positioned myocardial contrast echocardiography as a safe and feasible techniq
27 ological advances have positioned myocardial contrast echocardiography as a safe, practical bedside t
28 y underwent high-mechanical-index myocardial contrast echocardiography at 15 Hz to allow measurement
29 hage (n = 12) for 1 week prior to myocardial contrast echocardiography at 85% of gestation.
30 iovenous shunting was evaluated using saline contrast echocardiography at each stage.
31                                On myocardial contrast echocardiography, both MB(YSPSL) and MB(Ab) pro
32                                   Myocardial contrast echocardiography can assess myocardial perfusio
33                                   Myocardial contrast echocardiography can be used to assess perfusio
34                                              Contrast echocardiography can rapidly and accurately pro
35  nonrejecting myocardium and that myocardial contrast echocardiography can therefore detect acute rej
36                                              Contrast echocardiography (CE) has improved visualizatio
37 ardiography (HE), and after intravenous (IV) contrast echocardiography (CE) using a score for each of
38                                   Myocardial contrast echocardiography compares favorably with LDDE i
39                                    Real-time contrast echocardiography defect size and quantitative r
40                                    Real-time contrast echocardiography defect size varies throughout
41        MBF can be quantified with myocardial contrast echocardiography during a venous infusion of mi
42                                              Contrast echocardiography for detection of intrapulmonar
43 phy for assessment of inotropic reserve, and contrast echocardiography for evaluation of microvascula
44  teams; 3) use of (3-dimensional) myocardial contrast echocardiography for selecting the correct sept
45                              Agitated saline contrast echocardiography had high sensitivity but low s
46                                   Myocardial contrast echocardiography has been shown to have good co
47 erfusion analysis using real-time myocardial contrast echocardiography has been shown to have higher
48                                   Myocardial contrast echocardiography has been studied in multiple c
49 sis of myocardial perfusion using myocardial contrast echocardiography has higher diagnostic accuracy
50 dex imaging techniques (real-time myocardial contrast echocardiography) have the advantage of permitt
51 , magnetic resonance imaging, and myocardial contrast echocardiography, have emerged as techniques wi
52                                              Contrast echocardiography identified three patients with
53                                   Myocardial contrast echocardiography images and radiolabeled micros
54 n (MP) imaging during dipyridamole real-time contrast echocardiography improves the sensitivity to de
55 t with continuous high-mechanical-index (MI) contrast echocardiography in 15 open-chest dogs.
56                                   Myocardial contrast echocardiography in a short-axis (open-chest) o
57 a review of the current status of myocardial contrast echocardiography in acute coronary syndromes.
58 xciting exploration of the expanding role of contrast echocardiography in clinical practice.
59                                  The role of contrast echocardiography in enhancing technically diffi
60 hnique for assessing myocardial perfusion by contrast echocardiography in humans.
61 creased during hypoglycemia using myocardial contrast echocardiography in patients with type 1 diabet
62 ontrast agent microbubbles during myocardial contrast echocardiography in rats, and the numbers of in
63              The study examined the value of contrast echocardiography in the assessment of left vent
64 with impaired tissue perfusion on myocardial contrast echocardiography in the setting of myocardial i
65              Recent technical innovations in contrast echocardiography, including pulse inversion ima
66            Advances in novel applications of contrast echocardiography, including targeted delivery o
67                                              Contrast echocardiography indicated both pulmonary and m
68                                   Myocardial contrast echocardiography induces bioeffects in rat hear
69                                  Integrating contrast echocardiography into the ED evaluation of CP m
70                                   Myocardial contrast echocardiography is a new technique that utiliz
71                                   Myocardial contrast echocardiography is a recently developed techni
72                        We have reported that contrast echocardiography is a sensitive screening test
73                                              Contrast echocardiography is extremely sensitive, but no
74                                       Bubble contrast echocardiography is more sensitive in detecting
75 surgical septal reduction therapy, guided by contrast echocardiography, is an effective procedure for
76    Postdestruction time-intensity myocardial contrast echocardiography kinetic data were fit to the e
77                                     However, contrast echocardiography lacks specificity because many
78                                   Myocardial contrast echocardiography may be more versatile than per
79 esigned to determine the value of myocardial contrast echocardiography (MCE) and dobutamine echocardi
80 etermine the relative accuracy of myocardial contrast echocardiography (MCE) and low-dose dobutamine
81 of each free wall was measured by myocardial contrast echocardiography (MCE) and terminal morphometri
82 sought to compare the accuracy of myocardial contrast echocardiography (MCE) and wall motion analysis
83                           Because myocardial contrast echocardiography (MCE) assesses microvascular p
84 for detecting microbubbles during myocardial contrast echocardiography (MCE) based on the registratio
85 is study was to determine whether myocardial contrast echocardiography (MCE) can be used to detect co
86 f the study was to assess whether myocardial contrast echocardiography (MCE) can identify underlying
87 is study investigated whether (1) myocardial contrast echocardiography (MCE) can quantify changes in
88 ne whether three-dimensional (3D) myocardial contrast echocardiography (MCE) could provide an accurat
89 is study was to determine whether myocardial contrast echocardiography (MCE) during exogenous vasodil
90                                   Myocardial contrast echocardiography (MCE) has been used to evaluat
91                                   Myocardial contrast echocardiography (MCE) has been used to measure
92                                   Myocardial contrast echocardiography (MCE) has evolved into an impo
93                                   Myocardial contrast echocardiography (MCE) has undergone many advan
94 ermittent triggered and real-time myocardial contrast echocardiography (MCE) have been proposed to de
95 ta on the accuracy of intravenous myocardial contrast echocardiography (MCE) in detecting myocardial
96  accuracy of real-time imaging of myocardial contrast echocardiography (MCE) in detecting myocardial
97 Although defects on intracoronary myocardial contrast echocardiography (MCE) indicate loss of viabili
98                                   Myocardial contrast echocardiography (MCE) is an emerging technique
99 authors hypothesized that bedside myocardial contrast echocardiography (MCE) ischemic memory imaging
100 validate the ability of real-time myocardial contrast echocardiography (MCE) measures of opacificatio
101 ons, Albunex microbubbles used in myocardial contrast echocardiography (MCE) pass unimpeded through t
102    We sought to determine whether myocardial contrast echocardiography (MCE) performed before and ear
103  bundle-branch block (LBBB) using myocardial contrast echocardiography (MCE) to ascertain the value o
104 examined the ability of real-time myocardial contrast echocardiography (MCE) to delineate abnormaliti
105                           We used myocardial contrast echocardiography (MCE) to evaluate the therapeu
106 rtaken to evaluate the ability of myocardial contrast echocardiography (MCE) to guide the targeted de
107 was to evaluate the potential for myocardial contrast echocardiography (MCE) to provoke microscale bi
108 s the feasibility and accuracy of myocardial contrast echocardiography (MCE) using standard imaging a
109                                   Myocardial contrast echocardiography (MCE) was performed before occ
110                                   Myocardial contrast echocardiography (MCE) was performed with high
111 tered as a constant infusion, and myocardial contrast echocardiography (MCE) was performed with the u
112 utamine echocardiography (DE) and myocardial contrast echocardiography (MCE) was superior to either t
113              We hypothesized that myocardial contrast echocardiography (MCE) with leukocyte-targeted
114 de microbubble (SonoVue)-enhanced myocardial contrast echocardiography (MCE) with single-photon emiss
115 tery, whether normal perfusion by myocardial contrast echocardiography (MCE) would accurately predict
116 luate the comparative accuracy of myocardial contrast echocardiography (MCE), quantitative rest-redis
117 eled microsphere-derived MBF, and myocardial contrast echocardiography (MCE)-derived myocardial perfu
118 ied noninvasively in humans using myocardial contrast echocardiography (MCE).
119  pharmacological stress agent for myocardial contrast echocardiography (MCE).
120 onic myocardial ischemia by using myocardial contrast echocardiography (MCE).
121 23 patients undergoing concurrent myocardial contrast echocardiography (MCE).
122                                   Myocardial contrast echocardiography molecular imaging was performe
123 ernating myocardium include 99mTc-sestamibi, contrast echocardiography, nuclear magnetic resonance sp
124                                   Myocardial contrast echocardiography performed early after PCS prov
125 ubble kinetics using quantitative myocardial contrast echocardiography permits the evaluation of myoc
126       Albumin microbubbles that are used for contrast echocardiography persist within the myocardial
127                                   Myocardial contrast echocardiography provides better sensitivity th
128 hocardiography during dipyridamole real-time contrast echocardiography provides independent, incremen
129 on/reperfusion using quantitative myocardial contrast echocardiography (QMCE).
130                           Tissue Doppler and contrast echocardiography recently have emerged as impor
131                                   Myocardial contrast echocardiography risk area size (expressed as a
132 erfusion imaging (MPI) obtained by real-time contrast echocardiography (RTCE) and intravenous ultraso
133 ardial perfusion (MP) imaging with real-time contrast echocardiography (RTCE) improves the sensitivit
134 nt outcome after stress real-time myocardial contrast echocardiography (RTMCE) versus conventional st
135                   A positive agitated saline contrast echocardiography score was associated with anat
136                      Quantitative myocardial contrast echocardiography seems to overcome the expertis
137    QIPAVA , assessed by transthoracic saline contrast echocardiography, significantly increased as Pa
138  and portable hand-held echocardiography, to contrast echocardiography, stress echocardiography, and
139                   Imaging techniques such as contrast echocardiography suggest that anatomical intra-
140                                   Myocardial contrast echocardiography, thallium scintigraphy and any
141  measuring the increase in aBV on myocardial contrast echocardiography that occurs distally to the st
142                                           By contrast echocardiography, the bulging septum was locali
143 to evaluate the potential of second harmonic contrast echocardiography to assess coronary vasculature
144 ulsed and Doppler color flow ultrasound, and contrast echocardiography to evaluate flow in the ductus
145 010 underwent burst-replenishment myocardial contrast echocardiography to quantify myocardial perfusi
146                           We used myocardial contrast echocardiography to test the hypothesis that co
147 aim of this study was to evaluate myocardial contrast echocardiography using aortic root injections w
148                                   Myocardial contrast echocardiography using harmonic imaging and int
149 basis of detection of stenosis by myocardial contrast echocardiography using venous administration of
150                                           In contrast, echocardiography using harmonic imaging withou
151                                   Myocardial contrast echocardiography was achieved with intracoronar
152  flow through IPAVAs as detected with saline contrast echocardiography was not different between cond
153                                   Myocardial contrast echocardiography was performed after IV injecti
154                                    Real-time contrast echocardiography was performed at baseline, dur
155                         Triggered myocardial contrast echocardiography was performed during intraveno
156                                   Myocardial contrast echocardiography was performed during varying E
157                                   Myocardial contrast echocardiography was performed in six dogs to a
158                                              Contrast echocardiography was performed to assess RF and
159 vered as a constant infusion, and myocardial contrast echocardiography was performed using different
160                                   Myocardial contrast echocardiography was performed using intravenou
161               Low-power real-time myocardial contrast echocardiography was performed with flash impul
162              Perfusion defects on myocardial contrast echocardiography were measured during coronary
163 ng (WT) and myocardial perfusion (myocardial contrast echocardiography) were assessed at each stage.
164 scular reserve, studied by use of myocardial contrast echocardiography, were measured both before and
165                   At the start of myocardial contrast echocardiography, which lasted 10 minutes, perf
166                                   Myocardial contrast echocardiography with 1:4 electrocardiographic
167 Hg (or > or =20 mm Hg if age > 64 years) and contrast echocardiography with late appearance of microb

 
Page Top